Prophylactic Anticoagulation in Nephrotic Syndrome.
作者信息
Gerstein Jonathon, Battu Kiran, Reich Heather N
机构信息
Department of Medicine , University of Toronto , Division of Nephrology, University Health Network, Toronto , Ontario , Canada.
Department of Pharmacy , University Health Network , Toronto , Ontario , Canada.
出版信息
Kidney360. 2023 Oct 1;4(10):1476-1478. doi: 10.34067/KID.0000000000000225.
Abstract
摘要
相似文献
1
Prophylactic Anticoagulation in Nephrotic Syndrome.肾病综合征的预防性抗凝治疗
Kidney360. 2023 Oct 1;4(10):1476-1478. doi: 10.34067/KID.0000000000000225.
2
Prophylactic Anticoagulation in Adult Patients with Nephrotic Syndrome.成年肾病综合征患者的预防性抗凝治疗
Clin J Am Soc Nephrol. 2020 Jan 7;15(1):123-125. doi: 10.2215/CJN.05250419. Epub 2019 Oct 1.
3
Nephrotic Syndrome - Different Risk of Venous Thromboembolism with Different Approaches to Justify Prophylactic Anticoagulation.肾病综合征 - 不同的抗凝预防策略有不同的静脉血栓栓塞风险。
Angiology. 2023 Jul;74(6):519-525. doi: 10.1177/00033197221126248. Epub 2022 Sep 13.
4
Prophylactic oral anticoagulation in nephrotic patients with idiopathic membranous nephropathy.特发性膜性肾病肾病患者的预防性口服抗凝治疗
Kidney Int. 1994 Feb;45(2):578-85. doi: 10.1038/ki.1994.75.
5
Thromboembolic complications in the nephrotic syndrome: pathophysiology and clinical management.肾病综合征中的血栓栓塞并发症：病理生理学与临床管理
Thromb Res. 2006;118(3):397-407. doi: 10.1016/j.thromres.2005.03.030. Epub 2005 Jun 28.
6
Prophylaxis with AT III for thromboembolism in nephrotic syndrome: why should it be done?用抗凝血酶III预防肾病综合征中的血栓栓塞：为何要进行预防？
Int Urol Nephrol. 2009;41(3):713-6. doi: 10.1007/s11255-008-9434-8. Epub 2008 Aug 12.
7
Retrospective analysis of a novel regimen for the prevention of venous thromboembolism in nephrotic syndrome.肾病综合征中新型预防静脉血栓栓塞症方案的回顾性分析。
Clin J Am Soc Nephrol. 2014 Mar;9(3):478-83. doi: 10.2215/CJN.07190713. Epub 2013 Dec 12.
8
Nephrotic syndrome and anticoagulant therapy.肾病综合征与抗凝治疗。
Intern Med. 1998 Feb;37(2):210-2. doi: 10.2169/internalmedicine.37.210.
9
Epidemiology and pathophysiology of nephrotic syndrome-associated thromboembolic disease.肾病综合征相关血栓栓塞疾病的流行病学和病理生理学。
Clin J Am Soc Nephrol. 2012 Mar;7(3):513-20. doi: 10.2215/CJN.10131011. Epub 2012 Feb 16.
10
Research progress of nephrotic syndrome accompanied by thromboembolism.肾病综合征合并血栓栓塞症的研究进展。
Int Urol Nephrol. 2023 Jul;55(7):1735-1745. doi: 10.1007/s11255-023-03474-8. Epub 2023 Feb 9.
引用本文的文献
1
Venous Thromboembolism Prevention in Nephrotic Syndrome: The Role of Aspirin, Vitamin K Antagonists, and Direct Oral Anticoagulants.肾病综合征中的静脉血栓栓塞预防：阿司匹林、维生素K拮抗剂及直接口服抗凝剂的作用
Kidney Int Rep. 2025 Feb 21;10(5):1335-1345. doi: 10.1016/j.ekir.2025.02.010. eCollection 2025 May.
本文引用的文献
1
Association Between CKD and Major Hemorrhage in Older Persons: Data From the Aspirin in Reducing Events in the Elderly Randomized Trial.慢性肾脏病与老年人重大出血之间的关联：来自阿司匹林减少老年人事件随机试验的数据。
Kidney Int Rep. 2023 Jan 19;8(4):737-745. doi: 10.1016/j.ekir.2023.01.012. eCollection 2023 Apr.
2
Pharmacokinetics and Pharmacodynamics of Apixaban in Nephrotic Syndrome: Findings From a Phase 1a Trial.阿哌沙班在肾病综合征中的药代动力学和药效学：1a期试验结果
Am J Kidney Dis. 2023 Mar;81(3):373-376. doi: 10.1053/j.ajkd.2022.09.011. Epub 2022 Nov 1.
3
The Risk of Cardiovascular Events in Individuals With Primary Glomerular Diseases.原发性肾小球疾病患者的心血管事件风险。
Am J Kidney Dis. 2022 Dec;80(6):740-750. doi: 10.1053/j.ajkd.2022.04.005. Epub 2022 Jun 1.
4
Safety and Efficacy of Direct Oral Anticoagulants Versus Warfarin in Patients With Chronic Kidney Disease and Atrial Fibrillation.直接口服抗凝剂与华法林在慢性肾脏病合并心房颤动患者中的安全性和疗效。
Am J Cardiol. 2020 Jan 15;125(2):210-214. doi: 10.1016/j.amjcard.2019.10.033. Epub 2019 Nov 1.
5
Drug interactions between direct-acting oral anticoagulants and calcineurin inhibitors during solid organ transplantation: considerations for therapy.直接作用口服抗凝剂与钙调磷酸酶抑制剂在实体器官移植中的药物相互作用：治疗注意事项。
Expert Rev Clin Pharmacol. 2019 Aug;12(8):781-790. doi: 10.1080/17512433.2019.1637733. Epub 2019 Jul 4.
6
Impact of serum albumin levels on supratherapeutic PT-INR control and bleeding risk in atrial fibrillation patients on warfarin: A prospective cohort study.血清白蛋白水平对华法林治疗的心房颤动患者超治疗性凝血酶原时间-国际标准化比值（PT-INR）控制及出血风险的影响：一项前瞻性队列研究。
Int J Cardiol Heart Vasc. 2019 Jan 17;22:111-116. doi: 10.1016/j.ijcha.2019.01.002. eCollection 2019 Mar.
7
Venous thromboembolism in patients with membranous nephropathy.膜性肾病患者的静脉血栓栓塞症。
Clin J Am Soc Nephrol. 2012 Jan;7(1):43-51. doi: 10.2215/CJN.04250511. Epub 2011 Nov 10.
8
Disease-specific risk of venous thromboembolic events is increased in idiopathic glomerulonephritis.特发性肾小球肾炎患者静脉血栓栓塞事件的风险增加。
Kidney Int. 2012 Jan;81(2):190-5. doi: 10.1038/ki.2011.312. Epub 2011 Sep 14.
9
High frequency of aspirin resistance in patients with nephrotic syndrome.肾病综合征患者阿司匹林抵抗的发生率较高。
Nephrol Dial Transplant. 2012 Apr;27(4):1460-6. doi: 10.1093/ndt/gfr476. Epub 2011 Aug 23.
10
A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study.一种新的预测华法林相关出血风险的方案：ATRIA（心房颤动抗凝和危险因素）研究。
J Am Coll Cardiol. 2011 Jul 19;58(4):395-401. doi: 10.1016/j.jacc.2011.03.031.
Zotero 插件